Changan District Sheng Peptide Trading
Retatrutide
Finnrick tested 5 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Changan District Sheng Peptide Trading between 10 Sep 2025 and 22 Dec 2025. Test scores average below 4 or some scores below 3, and at least 2 tests, warrant a tentative Finnrick Rating of E (Bad).
Finnrick Rating™
Tentative Rating
Changan District Sheng Peptide Trading
Retatrutide
Tested 5 Samples
Last test 22 Dec 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Changan District Sheng Peptide Trading
Samples are tested in commercial labs
Tests Count
5
Scores
AVGMINMAX
Last
22 Dec 2025
First
10 Sep 2025
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 22 Dec 2025 | View | 20mg | ⚠️ Sample does not contain Retatrutide | not detected | (no batch ID) | White Label / Gold Crimp / Clear Cap | Lab E | Public | |||
| 25 Nov 2025 | View | 20mg | 20.1mg | +0.5% | 99.95% | n/a | (no batch ID) | No Label / Gold Crimp / Clear Cap | Lab E | Public | |
| 5 Oct 2025 | View | 15mg | 14.6mg | -2.7% | 99.79% | n/a | Jul 15, 2025 | No Label / Silver Crimp / Orange Cap | Lab E | Public | |
| 30 Sep 2025 | View | 10mg | 9.39mg | -6.1% | 99.93% | n/a | July 15 2025 | No Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 10 Sep 2025 | View | 20mg | 18.4mg | -8.0% | 99.95% | n/a | (no batch ID) | No Label / Gold Crimp / Clear Cap | Lab E | Public | |